NCI Specialized Programs of Research Excellence (SPORE) at UCSF
The NCI currently funds 52 Specialized Programs of Research Excellence (SPORE) grants which are located at 52 academic centers in 21 states across the United States, including the following at UCSF:
The Brain Tumor SPORE represents the translational research component of the Cancer Center’s Neurologic Oncology Program, which brings together neurosurgeons, neuro-oncologists, and basic scientists with the shared goal of improving the therapy of brain tumors.
Administrator: Larissa Best, [email protected] | (415) 502-5047
The DHART SPORE represents the translational research component of the Cancer Center’s Pediatric Malignancies Program, which brings together basic and clinical researchers with the shared goal of improving the outcome for children with cancer.
The Head and Neck Cancer SPORE is a collaboration with UPMC Hillman Cancer Center Head and Neck Cancer to improve detection and treatment of head, neck, and oral cavity cancers, and to understand the mechanisms of susceptibility to these cancers.
About the NCI Specialized Programs of Research Excellence (SPORE)
The Translational Research Program (TRP) is the home of the SPOREs — the Specialized Programs of Research Excellence — a cornerstone of NCI’s efforts to promote collaborative, interdisciplinary translational cancer research. SPORE grants involve both basic and clinical/applied scientists working together and support projects that will result in new and diverse approaches to the prevention, early detection, diagnosis and treatment of human cancers.
Each SPORE is focused on a specific organ site, such as breast or lung cancer, on a group of highly related cancers, such as gastrointestinal cancers and sarcomas, or on a common pathway or theme that ties together the cancers under study. SPOREs are designed to enable the rapid and efficient movement of basic scientific findings into clinical settings, as well as to determine the biological basis for observations made in individuals with cancer or in populations at risk for cancer.
> read more